SARS-CoV-2 (COVID-19) S protein, His-Tag, stabilized trimer Size:100µg BAFF has emerged as a

BAFF has emerged as a promising therapeutic target for the treatment of autoimmune disorders and B-cell malignancies

including tissue morphogenesis and repair

It is recommended to improve cleavage efficiency for each fusion protein by varying the amount of recombinant blueTEV

bronchial epithelial cells

and pharmacokinetic profiles

SARS-CoV-2 (COVID-19) S protein, His-Tag, stabilized trimer Size:100µg BAFF has emerged as aRecombinant Spike protein of SARS CoV 2 (COVID 19) from Wuhan pneumonia virus with C terminal Strep and His Tag as a stabilized trimer and with deletion of the internal Furin site. The S protein plays key parts in the induction of neutralizing antibody and T cell responses, as well as protective immunity. Overview Product Name: SARS CoV 2 (COVID 19) S protein, His Tag, stabilized trimer Catalog No.: P2020 025 RefSeq Links: NC_045512. 2; MN908947. 3;